Recent investigations suggest genetic susceptibility of allopurinol-induced severe cutaneous adverse reactions (SCARs). However, the strength of association was variable according to phenotypes and ethnic backgrounds. To explore genetic markers for allopurinol-induced SCARs in Koreans, we genotyped human leukocyte antigen (HLA) class I alleles of 25 cases of allopurinol-induced SCARs (20 cases of drug-induced hypersensitivity syndrome and five cases of Stevens–Johnson syndrome/toxic epidermal necrolysis) and 57 patients tolerant to allopurinol. Frequencies of B*5801 [92.0 vs. 10.5%, P c=2.45×10−11, odds ratio (OR)=97.8], Cw*0302 (92.0 vs. 12.3%, P c=9.39×10−11, OR=82.1), and A*3303 (88.0 vs. 26.3%, P c=3.31&tim...
Severe cutaneous adverse reactions (SCARs)- Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolys...
Background Thus far, human leukocyte antigen (HLA)-B ∗ 58:01 has been recognized as the ...
Background: Despite some studies suggesting a possible association between human leukocyte antigen, ...
Recent investigations suggest genetic susceptibility of allopurinol-induced severe cutaneous adverse...
Background HLA-B*58:01 is a well-known risk factor for allopurinol-induced severe cutaneous adverse ...
Background: Allopurinol has been reported as a common cause of severe cutaneous adverse reactions (S...
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are represented by rare but life...
Background: HLA-B*58:01 is a well-known risk factor for allopurinol-induced severe cutaneous adverse...
Abstract Allopurinol, a commonly prescribed medication for gout and hyperuricemia, is a frequent cau...
Severe cutaneous adverse drug reactions (SCARs) including Stevens-Johnson syndrome (SJS), toxic epid...
Background: Studies have suggested a possible association between HLA-B*5801 and allopurinol induced...
Allopurinol (ALP) is commonly used as a drug for gout treatment. However, ALP is known to cause cuta...
Background: Allopurinol is the most commonly used drug for the treatment of gout arthritis. However,...
BACKGROUND: Allopurinol is the most common cause of severe cutaneous adverse reactions (SCARs) in ...
BACKGROUND: Thus far, human leukocyte antigen (HLA)-B*58:01 has been recognized as the most importan...
Severe cutaneous adverse reactions (SCARs)- Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolys...
Background Thus far, human leukocyte antigen (HLA)-B ∗ 58:01 has been recognized as the ...
Background: Despite some studies suggesting a possible association between human leukocyte antigen, ...
Recent investigations suggest genetic susceptibility of allopurinol-induced severe cutaneous adverse...
Background HLA-B*58:01 is a well-known risk factor for allopurinol-induced severe cutaneous adverse ...
Background: Allopurinol has been reported as a common cause of severe cutaneous adverse reactions (S...
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are represented by rare but life...
Background: HLA-B*58:01 is a well-known risk factor for allopurinol-induced severe cutaneous adverse...
Abstract Allopurinol, a commonly prescribed medication for gout and hyperuricemia, is a frequent cau...
Severe cutaneous adverse drug reactions (SCARs) including Stevens-Johnson syndrome (SJS), toxic epid...
Background: Studies have suggested a possible association between HLA-B*5801 and allopurinol induced...
Allopurinol (ALP) is commonly used as a drug for gout treatment. However, ALP is known to cause cuta...
Background: Allopurinol is the most commonly used drug for the treatment of gout arthritis. However,...
BACKGROUND: Allopurinol is the most common cause of severe cutaneous adverse reactions (SCARs) in ...
BACKGROUND: Thus far, human leukocyte antigen (HLA)-B*58:01 has been recognized as the most importan...
Severe cutaneous adverse reactions (SCARs)- Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolys...
Background Thus far, human leukocyte antigen (HLA)-B ∗ 58:01 has been recognized as the ...
Background: Despite some studies suggesting a possible association between human leukocyte antigen, ...